ArticleJournal for immunotherapy of cancer2020

Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer.

Shaobo Mo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.